Novo Integrated Sciences, Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5297ebb6-4b87-4185-815f-6bc6d949ff16/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $13.3M | 2023-09-01 – 2024-08-31 | evidence 0001493152-24-050606 |
| FY 2023 | $12.6M | 2022-09-01 – 2023-08-31 | evidence 0001493152-23-044893 |
| FY 2022 | $11.7M | 2021-09-01 – 2022-08-31 | evidence 0001493152-23-010679 |
| FY 2021 | $9.3M | 2020-09-01 – 2021-08-31 | evidence 0001493152-21-031449 |
| FY 2020 | $7.9M | 2019-09-01 – 2020-08-31 | evidence 0001493152-20-023201 |
| FY 2019 | $9.4M | 2018-09-01 – 2019-08-31 | evidence 0001493152-19-018107 |
| FY 2018 | $8.9M | 2017-09-01 – 2018-08-31 | evidence 0001493152-18-015238 |
| FY 2017 | $8.0M | 2016-09-01 – 2017-08-31 | evidence 0001493152-18-015238 |
| FY 2016 | $7.2M | 2015-09-01 – 2016-08-31 | evidence 0001493152-17-014422 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Novo Integrated Sciences, Inc. — all facts · Net Income · Operating Income